Ti3C2Tx MXene nanostructures have garnered attention for various catalytic applications due to their built-in electronic properties. Herein, we rationally design highly exfoliated two-dimensional Ti3C2Tx nanosheets (Tx= O, OH, and F)...

Only a few treatments are approved for coronavirus disease‐2019 (COVID‐19) infections, with continuous debate about their clinical impact. Repurposing antiviral treatments might prove the fastest way to identify effective therapy. This trial aimed to evaluate the efficacy and safety of sofosbuvir (SOF) plus daclatasvir (DCV) or ravidasvir (RDV) added to standard care (SOC) for patients with moderate and severe COVID‐19 infection. Multicentre parallel randomized controlled open‐label trial. One hundred and twenty eligible patients with moderate and severe COVID‐19 infection were randomized to one of the study arms. Ten days of treatment with SOF plus DCV or RDV in addition to the standard of care compared to SOC. Follow up in 7 days. Sum of the counted symptoms at 7 and 10 days, mean change in oxygen saturation level, viral negativity, and rate of intensive care unit (ICU) admission. Compared to SOC, the SOF‐DCV group experienced a significantly lower sum of the counted symptoms (fever, headache, generalized aches, or respiratory distress) combined with no evidence of deterioration (ICU admission and mechanical ventilation) on Days 7 and 10 of treatment. Oxygen saturation also significantly improved among the SOF‐DCV group compared to SOC starting from Day 4. The study also showed positive trends regarding the efficacy of SOF‐DCV with a lower incidence of mortality. On the other hand, adding SOF‐RDV to SOC did not show significant improvements in endpoints. The results support the efficacy and safety of SOF‐DCV as an add‐on to SOC for the treatment of moderate to severe COVID‐19 infections.

Titanium carbide (Ti3C2Tx) MXene possesses various unique physicochemical and catalytic properties.However, the electrochemical CO oxidation performance is not yet addressed experimentally. Herein, Ti3C2Tx (TX=OH, O, and F) ordered and exfoliated two-dimensional nanosheets ornamented with semispherical pallidum nanoparticles (2.5 Wt. %) with an average diameter of (10 ±1 nm) (denoted as Pd/Ti3C2Tx) is rationally designed for the electrochemical CO oxidation. The fabrication process is based on the selective chemical etching of Ti3AlC2 and delamination under sonication to form Ti3C2Tx nanosheets that are used as a substrate and reducing agent for supporting in situ growth of Pd nanoparticles via impregnation with Pd salt. Interestingly, Pd-free Ti3C2Tx displayed inferior CO oxidation activity, while Pd/Ti3C2Tx enhanced the CO oxidation activity substantially. This is attributed to the combination of outstanding physicochemical properties of Ti3C2Tx and the catalytic merits of Pd nanoparticles.

The synergetic effect is an effective approach to promote green hydrogen evolution reaction (HER), however not yet reported for ternary metal doped porous g-C3N4 fiber-like nanostructures. Herein we synthesized ternary...

No abstract

No abstract